Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Alexandra Voutsina

No Evidence of an Association of ERCC1 and ERCC2 Polymorphisms With Clinical Outcomes of Platinum-Based Chemotherapies in Non-Small Cell Lung Cancer: A Meta-Analysis

Lung Cancer

English

Related publications

ERCC1 and ERCC2 Polymorphisms Predict Clinical Outcomes of Oxaliplatin-Based Chemotherapies in Gastric and Colorectal Cancer: A Systemic Review and Meta-Analysis

Clinical Cancer Research

Cancer Research

Oncology

2011

English

ERCC1 mRNA Expression Is Associated With the Clinical Outcome of Non-Small Cell Lung Cancer Treated With Platinum-Based Chemotherapy

Genetics and Molecular Research

English

Association Between Polymorphisms in ERCC2 Gene and Oral Cancer Risk: Evidence From a Meta-Analysis

English

P3.01-70 Meta-Analysis of Metformin in Combination With Platinum Chemotherapy in Advanced Non-Squamous Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

English

Astragalus-Based Chinese Herbs and Platinum-Based Chemotherapy for Advanced Non–Small-Cell Lung Cancer: Meta-Analysis of Randomized Trials

Journal of Clinical Oncology

English

XPG Polymorphisms Are Associated With Prognosis of Advanced Non-Small Cell Lung Cancer Treated With Platinum-Based Doublet Chemotherapy

Genetics and Molecular Research

English

ERCC1 and Small Cell Lung Cancer

Journal of Thoracic Oncology

English

TP53 Mutation Is Associated With a Poor Clinical Outcome for Non-Small Cell Lung Cancer: Evidence From a Meta-Analysis

Molecular and Clinical Oncology

Cancer Research

Oncology

2016

English

Promoter Polymorphisms of TOP2A and ERCC1 Genes as Predictive Factors for Chemotherapy in Non‐small Cell Lung Cancer Patients

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Alexandra Voutsina

No Evidence of an Association of ERCC1 and ERCC2 Polymorphisms With Clinical Outcomes of Platinum-Based Chemotherapies in Non-Small Cell Lung Cancer: A Meta-Analysis

Related publications

ERCC1 and ERCC2 Polymorphisms Predict Clinical Outcomes of Oxaliplatin-Based Chemotherapies in Gastric and Colorectal Cancer: A Systemic Review and Meta-Analysis

ERCC1 mRNA Expression Is Associated With the Clinical Outcome of Non-Small Cell Lung Cancer Treated With Platinum-Based Chemotherapy

Association Between Polymorphisms in ERCC2 Gene and Oral Cancer Risk: Evidence From a Meta-Analysis

P3.01-70 Meta-Analysis of Metformin in Combination With Platinum Chemotherapy in Advanced Non-Squamous Non-Small Cell Lung Cancer

Astragalus-Based Chinese Herbs and Platinum-Based Chemotherapy for Advanced Non–Small-Cell Lung Cancer: Meta-Analysis of Randomized Trials

XPG Polymorphisms Are Associated With Prognosis of Advanced Non-Small Cell Lung Cancer Treated With Platinum-Based Doublet Chemotherapy

ERCC1 and Small Cell Lung Cancer

TP53 Mutation Is Associated With a Poor Clinical Outcome for Non-Small Cell Lung Cancer: Evidence From a Meta-Analysis

Promoter Polymorphisms of TOP2A and ERCC1 Genes as Predictive Factors for Chemotherapy in Non‐small Cell Lung Cancer Patients